The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis

Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination

(2017) Yiting Liu et al.   Acta Neuropathologica Communications

Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function

(2016) Rickard P.F. Lindblom et al.   CLINICAL IMMUNOLOGY

Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis

(2016) Iliana Michailidou et al.   GLIA

Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder

(2016) Svetlana Hakobyan et al.   Multiple Sclerosis Journal

Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder

(2016) Svetlana Hakobyan et al.   Multiple Sclerosis Journal

RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

(2015) Adam M. Kruszewski et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis

(2015) Shahin Aeinehband et al.   PLoS One

Complement activation in patients with neuromyelitis optica

(2014) Petra Nytrova et al.   JOURNAL OF NEUROIMMUNOLOGY

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis

(2014) Gillian Ingram et al.   Acta Neuropathologica Communications

Increased Soluble C5b-9 in CSF of Neuromyelitis Optica

(2013) H. Wang et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Dual role of Response gene to complement-32 in multiple sclerosis

(2012) Cosmin A. Tegla et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Systemic complement profiling in multiple sclerosis as a biomarker of disease state

(2012) G Ingram et al.   Multiple Sclerosis Journal

C5b-9-activated, Kv1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation

(2011) Cosmin A. Tegla et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Membrane attack by complement: the assembly and biology of terminal complement complexes

(2011) Cosmin A. Tegla et al.   IMMUNOLOGIC RESEARCH

Complement regulator factor H in multiple sclerosis

(2011) Gillian Ingram et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients

(2011) Yun Li et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Mannose binding lectin mediated complement pathway in multiple sclerosis

(2011) Janet Y. Kwok et al.   JOURNAL OF NEUROIMMUNOLOGY

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state

(2010) Gillian Ingram et al.   BRAIN

Elevated plasma C4a levels in multiple sclerosis correlate with disease activity

(2010) Gillian Ingram et al.   JOURNAL OF NEUROIMMUNOLOGY

Immunoglobulins and complement in postmortem multiple sclerosis tissue

(2009) Michael H. Barnett et al.   ANNALS OF NEUROLOGY

Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells

(2009) Matthew Fosbrink et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Epigenetic modifications induced by RGC-32 in colon cancer

(2009) Sonia I. Vlaicu et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Homogeneity of active demyelinating lesions in established multiple sclerosis

(2008) Esther C. W. Breij et al.   ANNALS OF NEUROLOGY